Brianne Whitley, CNP, of Dana-Farber, shares strategies for hot flashes, sexual health, survivorship planning, and clinical trial access for men.
|Videos|January 20, 2017
Krista Qualmann on Genetic Counseling and Testing for Patients with Cancer
Author(s)Krista Qualmann, MS, CGC
Krista Qualmann discusses hereditary cancer syndromes.
Advertisement
Krista Qualmann, MS, CGC, Memorial Hermann Mischer Neuroscience Institute at the Texas Medical Center and UTHealth, discusses hereditary cancer syndromes.
About 5% to 10% of cancers are caused by single-gene disorders. These hereditary cancer syndromes are most well-known for causing cancers such as breast cancer, ovarian cancer and endometrial cancer. They can also have a hand in colon cancer, brain tumors and melanoma.
Advertisement
Related to this article
Dana-Farber's Brianne Whitley, CNP, details red-flag symptoms, ER-positive biology, and why every man with breast cancer needs a genetic referral.
Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib in HER2+ MBC.
ABUS matched handheld ultrasound on cancer detection in women with dense breasts while lowering recall and short-interval follow-up rates.
Dr. Andrew Pecora on leading the first IV oncolytic virus trial, building a top-50 cancer center, and using AI to fix the cost of cancer care.
Two Winship nurses explain how to talk with breast cancer survivors about GLP-1 receptor agonists, from endocrine therapy to access barriers.
Life table analysis estimates residual ovarian cancer risk by current age and planned age at risk-reducing surgery.
For MBC Awareness Day, an NP and a former ICU nurse living with metastatic breast cancer discuss repeat education, biomarker testing, and support.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Sunvozertinib Now Available in US for Pretreated EGFR Exon 20+ NSCLC
2
FDA Grants Traditional Approval to Pembrolizumab in TMB-H Solid Tumors
3
Male Breast Cancer: Warning Signs, Biology, and Genetic Testing
4
Making Innovation Meaningful: Enabling Personalized Care in Multiple Myeloma
5